INS and type 2 diabetes mellitus: However, several lines of evidence has shown that insulin dramatically suppresses the production of SeP in the hepatocytes [1], [21], [22], suggesting that decreased insulin action in the liver may induces the elevation of circulating SeP in patients with type 2 diabetes.